Sekrecki, M., Sekrecka, A., Lattupally, R. R., Le, K., Jin, X., Mozes, C., Dwyer, B. G., Zhuang, Z., Romero, B. A., Pineda, J. M. B., Cao, X., Nguyen, L., Chen, V., Zhou, C. M., Wallace, J. A., Tanaka, K., Tiwari, C., Gabel, A., Kim, W. J., Stanley, R. F., Benbarche, S., Thind, J., Muruganandham, A., Zhang, T. Y., Greenberg, P. L., Gotlib, J. R., Mannis, G., Shomali, W. E., Salmasi, G., Kuo, C., Shanafelt, T., Singh, I., Inoue, D., Hansen, F. K., Gray, N. S., Rechem, C. V., Fakhri, B., Zhang, X., Lu, S. X. (2026). Oncogenic
                    <i>SF3B1</i>
                    mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerability. Blood. https://doi.org/10.1182/blood.2025029972